BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8224263)

  • 21. Chronic growth hormone administration does not suppress endogenous growth hormone secretion in patients with neurosecretory growth hormone dysfunction.
    Zadik Z; Limoni Y; Lieberman E
    Horm Res; 1991; 35(3-4):95-8. PubMed ID: 1806474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The assessment of growth hormone status in normal young adult males using a variety of provocative agents.
    Rahim A; Toogood AA; Shalet SM
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):557-62. PubMed ID: 8977752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders.
    Shaker AG; Fleming R; Jamieson ME; Yates RW; Coutts JR
    Fertil Steril; 1992 Nov; 58(5):919-23. PubMed ID: 1426376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist.
    Bahceci M; Ulug U; Turan E; Akman MA
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):93-8. PubMed ID: 16720073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in basal and stimulated growth hormone secretion in the aging rhesus monkey: a comparison of chair restraint and tether and vest sampling.
    Wheeler MD; Schutzengel RE; Barry S; Styne DM
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1501-7. PubMed ID: 2229308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation.
    Brambilla F; Ferrari E; Cavagnini F; Invitti C; Zanoboni A; Massironi R; Catalano M; Cocchi D; Müller EE
    Biol Psychiatry; 1989 Feb; 25(3):256-64. PubMed ID: 2536561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone response to growth hormone-releasing hormone stimulation in oligozoospermic patients.
    Rajmil O; Rodríguez-Espinosa J; Sarquella J; Castellet R; Oliver A; Queraltó JM
    Fertil Steril; 1994 Nov; 62(5):1039-43. PubMed ID: 7926116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of growth hormone-releasing factor for induction of superovulation.
    Volpe A; Coukos G; Barreca A; Giordano G; Artini PG; Genazzani AR
    Hum Reprod; 1991 Oct; 6(9):1228-32. PubMed ID: 1752922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No beneficial effects of human growth hormone therapy in normal ovulatory patients with a poor ovarian response to gonadotropins.
    Levron J; Lewit N; Erlik Y; Itskovitz-Eldor J
    Gynecol Obstet Invest; 1993; 35(2):65-8. PubMed ID: 8449446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women.
    Ovesen P; Vahl N; Fisker S; Veldhuis JD; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 1998 May; 83(5):1662-7. PubMed ID: 9589674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP; Corder R; Pralong FP; Gaillard RC
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of growth hormone in the control of gonadotropin secretion in adult male rats.
    Chandrashekar V; Bartke A
    Endocrinology; 1998 Mar; 139(3):1067-74. PubMed ID: 9492039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
    Jurema MW; Bracero NJ; Garcia JE
    Fertil Steril; 2003 Nov; 80(5):1156-61. PubMed ID: 14607567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization and quantification of binding sites for follicle-stimulating hormone, luteinizing hormone, growth hormone, and insulin-like growth factor I in sheep ovarian follicles.
    Eckery DC; Moeller CL; Nett TM; Sawyer HR
    Biol Reprod; 1997 Sep; 57(3):507-13. PubMed ID: 9282983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.